A case series demonstrated the effectiveness of RTX in four of five patients with anti-MDA5 antibody-positive JDM-associated ILD; one patient died of respiratory failure that had progressed before the commencement of RTX [119]. Here, IFIH1 is linked to interstitial lung disease.